Effect of metformin on residual cells after chemotherapy in a human lung adenocarcinoma cell line

Cancer chemotherapy, including molecular targeted therapy, has major limitations because it does not kill all the cancer cells; the residual cells survive until they acquire chemoresistance. In the present study, the combined effects of metformin and gefitinib were examined in vivo in a mouse xenogr...

Descripción completa

Detalles Bibliográficos
Autores principales: KITAZONO, SATORU, TAKIGUCHI, YUICHI, ASHINUMA, HIRONORI, SAITO-KITAZONO, MIYAKO, KITAMURA, ATSUSHI, CHIBA, TETSUHIRO, SAKAIDA, EMIKO, SEKINE, IKUO, TADA, YUJI, KUROSU, KATSUSHI, SAKAO, SEIICHIRO, TANABE, NOBUHIRO, IWAMA, ATSUSHI, YOKOSUKA, OSAMU, TATSUMI, KOICHIRO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834555/
https://www.ncbi.nlm.nih.gov/pubmed/24100792
http://dx.doi.org/10.3892/ijo.2013.2120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834555/
https://www.ncbi.nlm.nih.gov/pubmed/24100792
http://dx.doi.org/10.3892/ijo.2013.2120

Ejemplares similares